556 related articles for article (PubMed ID: 16120478)
1. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
3. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
Morou E; Georgoussi Z
J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
[TBL] [Abstract][Full Text] [Related]
4. Selective interactions of spinophilin with the C-terminal domains of the δ- and μ-opioid receptors and G proteins differentially modulate opioid receptor signaling.
Fourla DD; Papakonstantinou MP; Vrana SM; Georgoussi Z
Cell Signal; 2012 Dec; 24(12):2315-28. PubMed ID: 22922354
[TBL] [Abstract][Full Text] [Related]
5. Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein.
Wang HY; Burns LH
J Neurobiol; 2006 Oct; 66(12):1302-10. PubMed ID: 16967511
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
7. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
[TBL] [Abstract][Full Text] [Related]
8. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
[TBL] [Abstract][Full Text] [Related]
9. Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins.
Georganta EM; Agalou A; Georgoussi Z
Neuropharmacology; 2010 Sep; 59(3):139-48. PubMed ID: 20433855
[TBL] [Abstract][Full Text] [Related]
10. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex.
Tesmer VM; Kawano T; Shankaranarayanan A; Kozasa T; Tesmer JJ
Science; 2005 Dec; 310(5754):1686-90. PubMed ID: 16339447
[TBL] [Abstract][Full Text] [Related]
11. RGS2 and RGS4 proteins: New modulators of the κ-opioid receptor signaling.
Papakonstantinou MP; Karoussiotis C; Georgoussi Z
Cell Signal; 2015 Jan; 27(1):104-14. PubMed ID: 25289860
[TBL] [Abstract][Full Text] [Related]
12. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
13. Pertussis-toxin-sensitive Galpha subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a heterotrimeric G-protein-channel complex.
Clancy SM; Fowler CE; Finley M; Suen KF; Arrabit C; Berton F; Kosaza T; Casey PJ; Slesinger PA
Mol Cell Neurosci; 2005 Feb; 28(2):375-89. PubMed ID: 15691717
[TBL] [Abstract][Full Text] [Related]
14. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
[TBL] [Abstract][Full Text] [Related]
15. A Purkinje cell specific GoLoco domain protein, L7/Pcp-2, modulates receptor-mediated inhibition of Cav2.1 Ca2+ channels in a dose-dependent manner.
Kinoshita-Kawada M; Oberdick J; Xi Zhu M
Brain Res Mol Brain Res; 2004 Dec; 132(1):73-86. PubMed ID: 15548431
[TBL] [Abstract][Full Text] [Related]
16. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
17. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
18. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
19. Allosteric regulation of GAP activity by phospholipids in regulators of G-protein signaling.
Tu Y; Wilkie TM
Methods Enzymol; 2004; 389():89-105. PubMed ID: 15313561
[TBL] [Abstract][Full Text] [Related]
20. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.
Roman DL; Talbot JN; Roof RA; Sunahara RK; Traynor JR; Neubig RR
Mol Pharmacol; 2007 Jan; 71(1):169-75. PubMed ID: 17012620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
